Journal of Virology, April 2002, p. 3852-3864, Vol. 76, No. 8
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.8.3852-3864.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Variability in the Human Immunodeficiency Virus Type 1 gp120 Env Protein Linked to Phenotype-Associated Changes in the V3 Loop
Noah G. Hoffman,1,2 Francoise Seillier-Moiseiwitsch,2,3,
JaeHyung Ahn,3 Jason M. Walker,2 and Ronald Swanstrom1,2*
Department of Microbiology and Immunology,1
UNC Center for AIDS Research,2
Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-72953
Received 13 July 2001/
Accepted 21 December 2001
Isolates of human immunodeficiency virus type 1 (HIV-1) are classified according to the chemokine receptor (coreceptor) used in conjunction with CD4 to target and enter cells: viruses using CCR5 and CXCR4 are classified as R5 and X4, respectively. The major determinant of entry-related HIV-1 phenotypes is known to reside in the third variable region of gp120 (V3). It is clear, however, that positions outside of V3 play some role in influencing phenotype, although marked context dependence and extensive variability among HIV-1 isolates have made the identification of these positions difficult. We used the presence of previously described substitutions in V3 to classify a large set of HIV-1 subtype B gp120 sequences available in public databases as X4-like or R5-like. Using these classifications, we searched for positions outside of V3 where either amino acid composition or variability differed significantly among sequences of different inferred phenotypes. Our approach took the epidemiological relationships among sequences into account. A cluster of positions linked to changes in V3 was identified between amino acids 190 and 204 of gp120, immediately C-terminal of V2; changes at position 440 in C4 were also linked to inferred phenotype. Structural data place these positions at the coreceptor-binding face of gp120 in a surface-exposed location. We also noted a significant increase in net positive charge in a highly variable region of V2. This study both confirms previous observations and predicts specific positions that contribute to a functional relationship between V3, V2, and C4.
* Corresponding author. Mailing address: 22-006 LCCC CB# 7295, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7295. Phone: (919) 966-5710. Fax: (919) 966-8212. E-mail: risunc{at}med.unc.edu.
Present address: Department of Mathematics and Statistics, University of Maryland, Baltimore County, Baltimore, Md.
Journal of Virology, April 2002, p. 3852-3864, Vol. 76, No. 8
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.8.3852-3864.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Huang, W., Toma, J., Fransen, S., Stawiski, E., Reeves, J. D., Whitcomb, J. M., Parkin, N., Petropoulos, C. J.
(2008). Coreceptor Tropism Can Be Influenced by Amino Acid Substitutions in the gp41 Transmembrane Subunit of Human Immunodeficiency Virus Type 1 Envelope Protein. J. Virol.
82: 5584-5593
[Abstract]
[Full Text]
-
Patel, M. B., Hoffman, N. G., Swanstrom, R.
(2008). Subtype-Specific Conformational Differences within the V3 Region of Subtype B and Subtype C Human Immunodeficiency Virus Type 1 Env Proteins. J. Virol.
82: 903-916
[Abstract]
[Full Text]
-
Lin, G., Bertolotti-Ciarlet, A., Haggarty, B., Romano, J., Nolan, K. M., Leslie, G. J., Jordan, A. P.-O., Huang, C.-c., Kwong, P. D., Doms, R. W., Hoxie, J. A.
(2007). Replication-Competent Variants of Human Immunodeficiency Virus Type 2 Lacking the V3 Loop Exhibit Resistance to Chemokine Receptor Antagonists. J. Virol.
81: 9956-9966
[Abstract]
[Full Text]
-
Bellamy-McIntyre, A. K., Lay, C.-S., Baar, S., Maerz, A. L., Talbo, G. H., Drummer, H. E., Poumbourios, P.
(2007). Functional Links between the Fusion Peptide-proximal Polar Segment and Membrane-proximal Region of Human Immunodeficiency Virus gp41 in Distinct Phases of Membrane Fusion. J. Biol. Chem.
282: 23104-23116
[Abstract]
[Full Text]
-
Huang, W., Eshleman, S. H., Toma, J., Fransen, S., Stawiski, E., Paxinos, E. E., Whitcomb, J. M., Young, A. M., Donnell, D., Mmiro, F., Musoke, P., Guay, L. A., Jackson, J. B., Parkin, N. T., Petropoulos, C. J.
(2007). Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations. J. Virol.
81: 7885-7893
[Abstract]
[Full Text]
-
Delobel, P., Nugeyre, M.-T., Cazabat, M., Pasquier, C., Marchou, B., Massip, P., Barre-Sinoussi, F., Israel, N., Izopet, J.
(2007). Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies. J. Clin. Microbiol.
45: 1572-1580
[Abstract]
[Full Text]
-
Kiselyeva, Y., Nedellec, R., Ramos, A., Pastore, C., Margolis, L. B., Mosier, D. E.
(2007). Evolution of CXCR4-Using Human Immunodeficiency Virus Type 1 SF162 Is Associated with Two Unique Envelope Mutations. J. Virol.
81: 3657-3661
[Abstract]
[Full Text]
-
Skrabal, K., Low, A. J., Dong, W., Sing, T., Cheung, P. K., Mammano, F., Harrigan, P. R.
(2007). Determining Human Immunodeficiency Virus Coreceptor Use in a Clinical Setting: Degree of Correlation between Two Phenotypic Assays and a Bioinformatic Model. J. Clin. Microbiol.
45: 279-284
[Abstract]
[Full Text]
-
Jensen, M. A., Coetzer, M., van 't Wout, A. B., Morris, L., Mullins, J. I.
(2006). A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope v3 sequences.. J. Virol.
80: 4698-4704
[Abstract]
[Full Text]
-
Westby, M., Lewis, M., Whitcomb, J., Youle, M., Pozniak, A. L., James, I. T., Jenkins, T. M., Perros, M., van der Ryst, E.
(2006). Emergence of CXCR4-Using Human Immunodeficiency Virus Type 1 (HIV-1) Variants in a Minority of HIV-1-Infected Patients following Treatment with the CCR5 Antagonist Maraviroc Is from a Pretreatment CXCR4-Using Virus Reservoir.. J. Virol.
80: 4909-4920
[Abstract]
[Full Text]
-
Pastore, C., Nedellec, R., Ramos, A., Pontow, S., Ratner, L., Mosier, D. E.
(2006). Human Immunodeficiency Virus Type 1 Coreceptor Switching: V1/V2 Gain-of-Fitness Mutations Compensate for V3 Loss-of-Fitness Mutations. J. Virol.
80: 750-758
[Abstract]
[Full Text]
-
Frost, S. D. W., Wrin, T., Smith, D. M., Pond, S. L. K., Liu, Y., Paxinos, E., Chappey, C., Galovich, J., Beauchaine, J., Petropoulos, C. J., Little, S. J., Richman, D. D.
(2005). Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. USA
102: 18514-18519
[Abstract]
[Full Text]
-
Heap, C. J., Wang, Y., Pinheiro, T. J. T., Reading, S. A., Jennings, K. R., Dimmock, N. J.
(2005). Analysis of a 17-amino acid residue, virus-neutralizing microantibody. J. Gen. Virol.
86: 1791-1800
[Abstract]
[Full Text]
-
Yuste, E., Borderia, A. V., Domingo, E., Lopez-Galindez, C.
(2005). Few Mutations in the 5' Leader Region Mediate Fitness Recovery of Debilitated Human Immunodeficiency Type 1 Viruses. J. Virol.
79: 5421-5427
[Abstract]
[Full Text]
-
Fulcher, J. A., Hwangbo, Y., Zioni, R., Nickle, D., Lin, X., Heath, L., Mullins, J. I., Corey, L., Zhu, T.
(2004). Compartmentalization of Human Immunodeficiency Virus Type 1 between Blood Monocytes and CD4+ T Cells during Infection. J. Virol.
78: 7883-7893
[Abstract]
[Full Text]
-
Pastore, C., Ramos, A., Mosier, D. E.
(2004). Intrinsic Obstacles to Human Immunodeficiency Virus Type 1 Coreceptor Switching. J. Virol.
78: 7565-7574
[Abstract]
[Full Text]
-
Brainard, D. M., Tharp, W. G., Granado, E., Miller, N., Trocha, A. K., Ren, X.-H., Conrad, B., Terwilliger, E. F., Wyatt, R., Walker, B. D., Poznansky, M. C.
(2004). Migration of Antigen-Specific T Cells Away from CXCR4-Binding Human Immunodeficiency Virus Type 1 gp120. J. Virol.
78: 5184-5193
[Abstract]
[Full Text]
-
Rybarczyk, B. J., Montefiori, D., Johnson, P. R., West, A., Johnston, R. E., Swanstrom, R.
(2004). Correlation between env V1/V2 Region Diversification and Neutralizing Antibodies during Primary Infection by Simian Immunodeficiency Virus sm in Rhesus Macaques. J. Virol.
78: 3561-3571
[Abstract]
[Full Text]
-
Kuhmann, S. E., Pugach, P., Kunstman, K. J., Taylor, J., Stanfield, R. L., Snyder, A., Strizki, J. M., Riley, J., Baroudy, B. M., Wilson, I. A., Korber, B. T., Wolinsky, S. M., Moore, J. P.
(2004). Genetic and Phenotypic Analyses of Human Immunodeficiency Virus Type 1 Escape from a Small-Molecule CCR5 Inhibitor. J. Virol.
78: 2790-2807
[Abstract]
[Full Text]
-
Jensen, M. A., Li, F.-S., van 't Wout, A. B., Nickle, D. C., Shriner, D., He, H.-X., McLaughlin, S., Shankarappa, R., Margolick, J. B., Mullins, J. I.
(2003). Improved Coreceptor Usage Prediction and Genotypic Monitoring of R5-to-X4 Transition by Motif Analysis of Human Immunodeficiency Virus Type 1 env V3 Loop Sequences. J. Virol.
77: 13376-13388
[Abstract]
[Full Text]
-
Goodenow, M. M., Rose, S. L., Tuttle, D. L., Sleasman, J. W.
(2003). HIV-1 fitness and macrophages. J. Leukoc. Biol.
74: 657-666
[Abstract]
[Full Text]
-
Poumbourios, P., Maerz, A. L., Drummer, H. E.
(2003). Functional Evolution of the HIV-1 Envelope Glycoprotein 120 Association Site of Glycoprotein 41. J. Biol. Chem.
278: 42149-42160
[Abstract]
[Full Text]
-
Johnston, E. R., Zijenah, L. S., Mutetwa, S., Kantor, R., Kittinunvorakoon, C., Katzenstein, D. A.
(2003). High Frequency of Syncytium-Inducing and CXCR4-Tropic Viruses among Human Immunodeficiency Virus Type 1 Subtype C-Infected Patients Receiving Antiretroviral Treatment. J. Virol.
77: 7682-7688
[Abstract]
[Full Text]
-
Kitrinos, K. M., Hoffman, N. G., Nelson, J. A. E., Swanstrom, R.
(2003). Turnover of env Variable Region 1 and 2 Genotypes in Subjects with Late-Stage Human Immunodeficiency Virus Type 1 Infection. J. Virol.
77: 6811-6822
[Abstract]
[Full Text]
-
Zwick, M. B., Kelleher, R., Jensen, R., Labrijn, A. F., Wang, M., Quinnan, G. V. Jr., Parren, P. W. H. I., Burton, D. R.
(2003). A Novel Human Antibody against Human Immunodeficiency Virus Type 1 gp120 Is V1, V2, and V3 Loop Dependent and Helps Delimit the Epitope of the Broadly Neutralizing Antibody Immunoglobulin G1 b12. J. Virol.
77: 6965-6978
[Abstract]
[Full Text]
-
Cilliers, T., Nhlapo, J., Coetzer, M., Orlovic, D., Ketas, T., Olson, W. C., Moore, J. P., Trkola, A., Morris, L.
(2003). The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C. J. Virol.
77: 4449-4456
[Abstract]
[Full Text]
-
Gordon, M., De Oliveira, T., Bishop, K., Coovadia, H. M., Madurai, L., Engelbrecht, S., Janse van Rensburg, E., Mosam, A., Smith, A., Cassol, S.
(2003). Molecular Characteristics of Human Immunodeficiency Virus Type 1 Subtype C Viruses from KwaZulu-Natal, South Africa: Implications for Vaccine and Antiretroviral Control Strategies. J. Virol.
77: 2587-2599
[Abstract]
[Full Text]
Copyright © 2002 by the American Society for Microbiology. All rights reserved.